Difference between retatrutide and tirzepatide Mounjaro is an approved medication for weight loss and type 2 diabetes in the UK, while retatrutide is still in development and currently going through phase 3 clinical trials
warmth afterward may ease residual soreness
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-comparator-controlled, parallel-group, phase 2 trial conducted in the USA
Ensuring adequate nutrition, even when appetite is reduced, helps mitigate this
Noom Health identified this dynamic early and developed Smart Rx specifically to address this challenge, giving employers a clinically grounded, cost-transparent alternative to traditional pharmacy benefit channels, while remaining rooted in Nooms best-in-class behavior change program
By pairing GLP-1 treatment with behavior change support and daily coaching, Noom helps members build the kind of habits that carry results forward over time
